Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.2.1.31 (beta-glucuronidase)
 7,680 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Lysosomal enzyme release occurs during cardiopulmonary bypass in man but the tissues from which these enzymes originate have not been identified. The activity of N-acetyl beta-glucosaminidase in plasma increases to a degree which is proportional to the duration of bypass and this enzyme may therefore be a better marker than beta-glucuronidase of tissue damage caused by cardiopulmonary bypass, as distinct from tissue damage solely to the operative procedure.
Anaesthesia 1977 Sep
PMID:Lysosomal enzyme release during cardiopulmonary bypass. 92 Sep 15

Mycophenolic acid, a new chemotherapeutic agent for the treatment of psoriasis, is known to be rapidly conjugated on absorption and to circulate largely in the form of its glucuronide conjugate. Since this metabolite does not readily penetrate intact cells and is cleaved by the enzyme beta-glucuronidase to yield free mycophenolic acid, the ability of preparations of mouse skin to cleave mycophenolic glucuronide was studied. The time course of mycophenolic acid liberation by such preparations and the dependence upon the amount of enzyme preparation were demonstrated. Preparations of mouse skin and mouse liver, kidney, spleen, lung, heart and small intestine were assayed for beta-glucuronidase activity using p-nitrophenyl-beta-D-glucuronide as substrate. Skin yielded preparations with higher beta-glucuronidase activity per/mg protein than any of the other organs tested. When expressed on the basis of beta-glucuronidase activity recovered per milligram of tissue DNA, skin, liver and kidney showed higher levels than the other organs tested.
Br J Dermatol 1977 Sep
PMID:Cutaneous beta-glucuronidase: cleavage of mycophenolic acid by preparations of mouse skin. 92 1

The biological transformation of phenyramidol (I), some of which is also excreted unchanged, occurs by three main degradative pathways: 1. Hydroxylation of the pyridine ring in position 3 (metabolite V) and 5 (metabolite VI). 2. Cleavage of the ethanolamine chain with the formation of 2-aminopyridine (metabolite II) and presumably mandelic aldehyde. 3. Conjugation with glucuronic acid (metabolite III). Secondary reactions result in the production of: benzoyl carbinol (metabolite XV), benzoic acid (metabolite XI), mandelic acid (metabolite XII) and the glucuronides of V, VI, VII, XII and possibly II (metabolites VIII, IX, X, XIII and IV), all of which were also found as free, unconjugated compounds. A further, unusual reaction is the dimerisation of metabolite VI with the formation of a dipyridyl derivative (metabolite VII), which is excreted partly as the free compound, but mainly as the glucuronide (metabolite X). The occurrence of 2-(N-benzylamino)-pyridine (XIV) in the urine could not be explained. Four futher excretory products (metabolites XVI, XVII, XVIII and XIX) were not identified; XVI and XVII were extracted at an alkaline pH, whereas XVIII and XIX were extracted under neutral conditions. They could be detected both as free compounds, and after hydrolysis with HCl or alkali, but not after treatment with beta-glucuronidase.
J Clin Chem Clin Biochem 1977 Sep
PMID:[Isolation and identification of some metabolites of phenyramidol (Cabral) from human urine (author's transl)]. 92 36

The changes in the activity of several lysosomal glycosidases of mouse brain which occured during an inapparent infection with the A774 strain (avirulent) of Semliki Forest Virus (SFV) have been related to the histopathological and viral changes caused by the disease. N-acetyl-beta-D-glucosaminidase, N-acetyl-beta-D-galactosaminidase and beta-glucuronidase were significantly elevated between post-inoculation day 7 and 28. Lesions characteristic of encephalitis were also observed between these times. Histochemical and biochemical of encephalitis were also observed between these times. Histochemical and biochemical observations showed that not all areas of brain were affected equally; the cerebellum, parts of the mid-brain and the spinal cord showed the most sevre biochemical and histochemical changes, whilst histopathological lesions were more evenly distributed. The biochemical results have been related to the histological, histochemical and virological findings and the production of glycosidases from 2 or more cellcular types has been postulated.
J Neurol Sci 1976 Sep
PMID:Effect of an inapparent viral encephalitis on the levels of lysosomal glycosidases in mouse brain. 95 May 73

A method for the detection of nanogram quantities of nylidrin in human urine is described. The method involves beta-glucuronidase hydrolysis, extraction with chloroform, derivatization by silylation, and GLC determination. The suitability of the method was tested by analysis of urine samples of subjects after oral ingestion of nylidrin hydrochloride.
J Pharm Sci 1976 Sep
PMID:GLC determination of nylidrin in human urine samples. 96 53

The activities of acid phosphatase and beta-glucuronidase were assayed in fetal and neonatal mouse epidermis by microanalytical methods. The level of acid phosphatase activity was low in the epidermis on Day 15 of gestation. Acid phosphatase activity increased 10-fold between Day 15 of gestation and neonatalhood. On the other hand, beta-glucuronidase activity was high on Days 14 and 15 of gestation and low after Day 17 of gestation. The relative ratio of acid phosphatase to beta-glucuronidase activity appeared to represent a marker for the degree of differentiation in whole epidermis.
Proc Soc Exp Biol Med 1976 Sep
PMID:Developmental patterns of acid hydrolases during differentiation of fetal mouse skin. 98 92

An electrophoretic technique was developed which allows the separation of human beta-glucuronidase (GUS EC 3.2.1.3.1) from the enzyme present in cultured murine. Chinese and Syrian hamster cells in one buffer system on Cellogel. Using this technique a number of independent human-mouse somatic cell hybrids have been analyzed for the segregation of GUS, other enzyme markers, and all human chromosomes. The results indicate that a structural gene for human beta-glucuronidase is located on chromosome C7.
Somatic Cell Genet 1976 Sep
PMID:Assignment of a structural gene for beta-glucuronidase to human chromosome C7. 102 50

The enzymes acid phosphatase (E.C. 3.133) and beta-glucuronidase (E.C. 3.2.1.31) have been demonstrated in dentin-resorbing cells by means of histochemistry. Addition of specific enzyme inhibitros revealed that the acid phosphatase of these cells was sensitive to fluride, copper, and m?OLYBDATE BUT RESISTANT TO Tartrate. The same pattern of enzyme activity has previously been found in bone-resorbing cells.
Oral Surg Oral Med Oral Pathol 1976 Sep
PMID:Histochemical demonstration of acid hydrolase activity in internal dentinal resorption. 106 36

The complement component, C5a provokes the selective release of granule-associated enzymes from the intact, viable cytochalasin B-treated human polymorphonuclear leukocytes (PMN) in the absence of phagocytosis or cellular adherence to surfaces. Consquently, in this experimental system the influence of divalent cations on these two processes can be disregarded and their effects on enzymes secretion can be studied directly. Cytochalasin B-treated PMN exposed to C5a in calcium and magnesium-free media consistently secreted significant amounts of the granule-associated enzymes, beta-glucuronidase and lysozyme. The basal secretory response was not diminished if cells were preincubated with 5.0 mM EDTA, nor was it influenced if 1.0 mm or 2.0 mM EDTA were present in the reaction mixtures. The addition of calcium (up to 1.5 to 2.0 mM) produced a concentration-dependent enhancement of beta-glucuronidase release, whereas increasing amounts of calcium (above 2.0 mM) inhibited secretion of this enzyme. Lysozyme release was similarly enhanced by the addition of calcium, but inhibition with high concentrations was not observed. Calcium per se, in the absence of C5a, provoked only the release of lysozyme from these cells. The effects of calcium upon enzyme release were not associated with alterations in the state of assembly of cytoplasmic microtubules. These findings provide another example of the role of calcium in "stimulus-secretion coupling" and provide evidence that exocytosis of various granules in human PMN is regulated by independent mechanisms involving calcium.
J Immunol 1975 Sep
PMID:Influence of divalent cations upon complement-mediated enzyme release from human polymorphonuclear leukocytes. 115 Oct 72

PMA enhanced release of the azurophil granule enzyme, beta-glucuronidase, as well as lysozyme, from cytochalasin B-treated PMN's exposed to either zymosan particles or C5a. PMA was active at nanomolar concentrations, was not toxic to the cells, and was most effective when present for brief durations (0-1 min) before exposure of the cells to the stimuli. Beta-glucuronidase was not released in significant amounts from PMN's exposed to PMA alone, in the absence of stimuli such as zymosan or C5a. In contrast, only the specific granule enzyme, lysozyme, was released from unstimulated cells. Electron micrographs of cells exposed to PMA revealed an increase in the number of visible cytoplasmic microtubules as compared to control cells. Enhancement of lysosomal enzyme (beta-glucuronidase) release by PMA appears to be independent of effects on release of specific granule enzymes (lysozyme), but rather is likely due to PMA-induced elevations of cellular cGMP.
J Cell Biol 1975 Sep
PMID:Mechanisms of lysosomal enzyme release from human polymorphonuclear leukocytes. Effects of phorbol myristate acetate. 115 73


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>